RADAR Skin Health is the work of clinicians, technologists and medical device specialists who shared one goal: to build a tele-dermatology solution that is truly fit for purpose in today’s clinical landscape.
Meet the teamClinicians, technologists and medical device specialists. One shared goal: better skin care.
Chairman
Paul has more than 40 years' experience in investment banking, including 15 years at Morgan Stanley, where he rose to Co-Head of Global Derivatives. His expertise spans financial structuring, capital raising and advisory work. He is a significant investor and shareholder in the business and holds directorships in related companies.
Founder & CEO
Edward brings more than 30 years' experience in mobile, IT, telematics and digital data capture for business. As founding director, he has focused the company on digital solutions that improve the operational efficiency of healthcare and reduce its environmental impact. He was UK National Winner of the Ernst & Young Entrepreneur of the Year award for Science & Technology in 2007, and has received a Platinum Titan Business Award.
Board Director
Robert spent more than 13 years in senior international roles at IBM before becoming Global Sales and Marketing Director at The Huon Corporation, leading to a multi-million-pound trade sale. He was Managing Director at The Innovation Group and later Deputy CEO of Watchstone plc's legal services division, where he played a key role in its £650 million sale. He holds other technology-company directorships.
Co-Founder & Head of Strategy
Richard is a technology leader with extensive experience of delivering solutions to the NHS and the wider public sector. He co-founded, and later led as managing director, a managed network services company that grew to 250 staff and more than £35 million in annual revenue before its acquisition by Capita plc.
Head of Operations & Compliance
Thomas is a MedTech executive, most recently Group COO at OpenRad, where he led the post-merger integration of four businesses across the UK and EU and secured FDA 510(k) clearance for US expansion. He was previously COO and then Head of Compliance at Visbion. His expertise covers software as a medical device, quality systems and standards including ISO 13485, ISO 14971, ISO 27001, MDR and DCB0129. His academic background is in cognitive neuroscience and clinical psychology.
Senior Computer Vision Engineer
Alistair is a computer vision and machine learning engineer with a background in academic research and full-stack development. At the University of Manchester he developed transformer-based models for breast cancer risk prediction, presented at SPIE 2025, and he previously worked as a software engineer at Omnibus. He holds an MSc in Advanced Computer Science from the University of Manchester and a BSc in Computer Science from Manchester Metropolitan University.
Consultant Dermatologist, London
Natasha qualified from Charing Cross and Westminster Medical School in 1992 and trained at leading London institutions. She pioneered photodynamic therapy in London teaching hospitals and is Clinical Lead at The Whittington Hospital and Joint Teaching Lead in Dermatology at UCL Medical School. She is a Principal Investigator in national and international clinical trials and works closely with GPs in community dermatology.
Senior Head and Neck Surgeon, Royal Marsden Hospital
Cyrus specialises in mucosal cancer and salivary gland disease. He holds honours degrees in medicine and dentistry from the University of London, has been a consultant since 1999 and has worked at the Royal Marsden since 2008. He has written a maxillofacial surgery textbook and more than 120 peer-reviewed publications, has chaired and led two NICE guidelines, and is a past President of both the British Association of Oral and Maxillofacial Surgeons and the British Association of Head and Neck Oncologists.
Head of AI, Simudyne
Namid leads AI research and development at Simudyne, including simulation-based and deep learning methods with applications in finance and healthcare. He holds a PhD in Engineering Mathematics and carried out postdoctoral research at the University of Bristol and University College London. He has written more than 20 peer-reviewed works and the book Graph Neural Networks in Action.
Neuroimaging, South London and Maudsley
Steve develops safe, non-invasive brain imaging techniques for neurology and psychiatry. He heads the Department of Neuroimaging and the Centre for Neuroimaging Sciences at the South London and Maudsley Hospital, where his research includes a dedicated head-only MRI system and faster, quieter imaging protocols for vulnerable patients.
Our approach
There are faster ways to build a skin app. We chose not to take them. Getting a clinical tool right means testing it with the people who will use it, refining it again and again, proving it is safe, and earning the trust of clinicians and patients.We took the time to do all of that.
Our team
Because no single discipline could build it alone, we set out to assemble a team with every skill the job required.
At the heart of the team are senior clinicians: a consultant dermatologist who has led departments and teaching in London’s leading hospitals, and a head and neck surgeon who has chaired national guidelines and led his specialty’s professional bodies. They know the skin pathway from the inside, and they have shaped every step of the product.
Alongside them are technology leaders who have spent decades building businesses, delivering complex systems into the NHS and the wider public sector, and growing companies through to successful exits. They know how to turn a clinical need into a product that works reliably at scale.
In healthcare, safe has to be proven, not promised. Our medical device and compliance specialists have taken products through UK and international regulation, and made clinical safety, quality and data protection part of the build from the very first day.
Our researchers in computer vision, imaging and artificial intelligence have helped us build on large banks of historical clinical images with confirmed diagnoses. That grounding in real-world data is what allows us to create something clinicians can rely on.
The work is supported by experienced investors who understand that building something worthwhile in healthcare takes patience as well as ambition.
The result is RADAR Skin Health. We believe it is one of the most comprehensive tele-dermatology solutions available to UK clinicians today: intuitive for patients and clinicians alike, and bringing together answers to many of the issues holding back skin care in a single platform.
We are proud of what this team has built. Now we want to see it in the hands of every GP practice, dermatology clinic and pharmacy ready to give their patients faster, more informed decisions.
Explore the platformSkin care in the UK is under real strain. Patients wait anxiously for answers, GPs juggle complex skin cases in short appointments, and scarce consultant time goes on rebuilding incomplete referrals.
1 in 4
people see their GP about a skin problem every year
>1,000,000
referrals to specialist dermatology each year
423,217
people waiting for dermatology treatment in England
Tele-dermatology was not a new idea, and these were not undiscovered problems: clinicians had been describing them for years. What was missing was a solution that brought all the answers together in one place, worked the way clinicians work, and met the standards healthcare demands.
We knew no single discipline could build that alone.
See how RADAR Skin Health could work in your GP practice, dermatology clinic or pharmacy. We will walk you through it and answer your questions.